News & Press Releases
Filter by:
Bloomberg Law featured Mintz’s addition of the five-partner antitrust litigation team led by Philip Iovieno and including Nicholas Gravante, Jr., Sean O’Shea, Michael Petrella, and Matthew Karlan.
Mintz has again been ranked by Patexia, a leading intellectual property platform, in its Intelligence Report, a comprehensive list of the “best performing” and “most active” ITC Section 337 attorneys and law firms.
Mintz Advises on Eupraxia Pharmaceuticals $63.2 Million Public Offering
February 27, 2026
Mintz advised the underwriters in connection with Eupraxia Pharmaceuticals’ $63.2 million public offering.
Mintz Represents Vercept in its Sale to Leading AI Company Anthropic
February 27, 2026
Mintz advised Vercept, a Seattle-based computer-use AI startup, in its sale to Anthropic, the leading AI safety and research company developing frontier-scale models and best known for its Claude family of large language models (LLMs).
5th Circuit Rejects FCC Rule, Says TCPA Allows Any Kind of Consent for Marketing Calls
February 27, 2026
Communications Daily featured insights from Member Esteban Morales in an article about a ruling from the 5th U.S. Circuit Court of Appeals which said that despite an FCC ruling that required prior written consent for telemarketing calls, the Telephone Consumer Protection Act indicates that oral consent is enough.
Healthcare CDMO Deals Set for 2026 Rebound as Exits and Specialization Accelerate – Dealspeak North America
February 27, 2026
Mergermarket recently featured insights from Cheryl Reicin, Life Sciences Practice Co-chair, in an article discussing a potential 2026 rebound in M&A activity across the contract development and manufacturing organization (CDMO) sector, which provides outsourced development and manufacturing services to biopharma and medical‑device companies.
